Vicept Therapeutics, Inc.

101 Lindenwood Drive, Suite 430,
Malvern, Pennsylvania 19355
United States,
(484)324-2930
www.vicepttx.com

Vicept Therapeutics, Inc. is a privately held specialty pharmaceutical company with a mission to develop the first effective topically applied therapy directed toward the erythema of rosacea and other disorders characterized by redness and or flushing of the skin.

Vicept Therapeutics was acquired by Allergan on July 19, 2011.

Join Mergr to view all 163 acquisitions of life science companies in 2011, including 17 acquisitions by private equity firms, and 146 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Vicept Therapeutics.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.